rs387906725
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000194.3(HPRT1):c.143G>A(p.Arg48His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000194.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPRT1 | NM_000194.3 | c.143G>A | p.Arg48His | missense_variant | Exon 3 of 9 | ENST00000298556.8 | NP_000185.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPRT1 | ENST00000298556.8 | c.143G>A | p.Arg48His | missense_variant | Exon 3 of 9 | 1 | NM_000194.3 | ENSP00000298556.7 | ||
HPRT1 | ENST00000462974.5 | n.301G>A | non_coding_transcript_exon_variant | Exon 3 of 8 | 3 | |||||
HPRT1 | ENST00000475720.1 | n.101G>A | non_coding_transcript_exon_variant | Exon 2 of 8 | 3 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
HPRT1-related disorder Pathogenic:2
Variant summary: HPRT1 c.143G>A (p.Arg48His) results in a non-conservative amino acid change located in the Phosphoribosyltransferase domain (IPR000836) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 183163 control chromosomes (gnomAD). c.143G>A has been reported in the literature in multiple individuals affected with HPRT1-Related Disorders (e.g., Sampat_2011). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, finding that the variant results in a reduced maximum rate of reaction in vitro and also leads to poor thermal stability (e.g., Sampat_2011). The following publication was ascertained in the context of this evaluation (PMID: 20981450). Three submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
The HPRT1 c.143G>A variant is predicted to result in the amino acid substitution p.Arg48His. This variant has been reported in multiple individuals with hyperuricemia with or without neurological symptoms (see for example, Table 1, Sege-Peterson et al. 1992. PubMed ID: 1301916; Table 1, Sampat et al. 2010. PubMed ID: 20981450; Sapag et al. 2012. PubMed ID: 22999896). This variant has not been reported in a large population database, indicating this variant is rare. An in vitro experimental study suggests this variant impacts protein function (Figure 1, Sampat et al. 2010. PubMed ID: 20981450). This variant is interpreted as pathogenic. -
Lesch-Nyhan syndrome;C0268117:Partial hypoxanthine-guanine phosphoribosyltransferase deficiency Pathogenic:1Other:1
Experimental studies have shown that this missense change affects HPRT1 function (PMID: 20981450, 25481104). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 29985). This missense change has been observed in individuals with HPRT1-related disease (PMID: 1301916, 10737990, 17454734, 20981450, 22157001, 22999896). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 48 of the HPRT1 protein (p.Arg48His). -
Variant interpreted as Pathogenic and reported on 09-23-2019 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
Lesch-nyhan syndrome, neurologic variant Pathogenic:1
- -
Partial hypoxanthine-guanine phosphoribosyltransferase deficiency Pathogenic:1
- -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at